What does the microdose program cost each month?

The program page states $79 for an initial three-week subscription that includes four weeks of medication, then $179 per month plus tax against a twelve-week subscription. Because twelve weeks is 84 days rather than three calendar months, three of those payments cover 2.76 months. The effective monthly cost is therefore higher than $179.

Why do two Noom pages give different prices?

The homepage footnote carries pricing dated March 31, 2026 and quotes $199 a month after the intro. The dedicated microdose page carries pricing dated July 27, 2026 and quotes $179. Both describe the same program with the same $79 opening, so the older footnote has simply not been updated.

Does Noom prescribe Wegovy and Zepbound?

Yes. Noom Med lists brand Wegovy, Ozempic, Zepbound, Mounjaro and the Wegovy pill alongside its own compounded programs. Brand access is described as starting at $39 plus the out-of-pocket cost of the medication, which depends on a buyer's insurance. That second component is never quantified on the site.

Is the compounded medication FDA-approved?

No. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. Noom states its compounded semaglutide is produced in an FDA-registered facility, which describes where it is made rather than any review of the product. Noom also states it has no affiliation with Novo Nordisk or Eli Lilly.

Is Noom expensive compared with other GLP-1 telehealth sellers providers?

Noom publishes a starting figure of $195/mo. Across the 226 GLP-1 telehealth sellers providers we review that publish a single monthly figure, those run $76 to $449 with a median of $179, which puts Noom above the median. The other 14 GLP-1 telehealth sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

Noom review

Price lives in a footnote

Noom's rate is set against a twelve-week subscription rather than a calendar month, and the sentence that says so is a footnote.

Our verdict

Noom sells both compounded and brand GLP-1s, and prices only the compounded programs. The figure appears nowhere on the product pages — it lives in a footnote reading that an initial three-week subscription and four weeks of medication start from $79, followed by a per-month rate for a twelve-week subscription. Three clock lengths govern one purchase, and none of them is a month. Twelve weeks is 84 days, so three payments buy 2.76 months of medication rather than three, which is what lifts the real cost above the number printed. The two programs also disagree with each other: the homepage footnote and the microdose program page quote different ongoing rates for the same plan.

Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Check availability →

At a glance

Category: GLP-1 telehealth
Molecule: Semaglutide · Tirzepatide
Form: Injection
Dose published: No
Prescription: Required
Compounded: Yes — not FDA-approved
Pharmacy: Not named
Labs: Not stated
Updated: September 2026

What it is

A behavior-change platform with a prescribing arm, Noom Med, selling its own compounded Noom GLP-1Rx and Microdose GLP-1Rx programs alongside access to brand Wegovy, Ozempic, Zepbound, Mounjaro, the Wegovy pill, Foundayo, generic liraglutide and metformin.

How it works

An intake survey, a clinician evaluation, then medication shipped where home delivery is available — which Noom states depends on insurance or cash-pay status. Every medication plan includes the Noom app, its psychology-based lessons, coaching and the GLP-1 Companion tools. Refills and clinician access continue where clinically appropriate. Noom states its service is not available in all 50 states.

Pricing transparency

The compounded programs are priced only in footnotes. The microdose program page states an initial three-week subscription with four weeks of medication from $79, then $179 per month plus tax for a twelve-week subscription thereafter, marked as new pricing effective July 27, 2026. The homepage footnote for the same program still reads $199. The standard program footnote reads $149 to start and $349 per month plus tax on a twelve-week subscription. Brand medications are described separately as starting at $39 plus whatever the drug itself costs under a buyer's coverage.

Branded vs compounded

The Noom GLP-1Rx and Microdose GLP-1Rx programs dispense compounded semaglutide and compounded tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. Noom prints that itself, adding that its compounded semaglutide comes from an FDA-registered facility that has not been reviewed for safety, efficacy or quality. Brand Wegovy, Ozempic, Zepbound and Mounjaro are available through the same clinicians and priced entirely differently.

Pros and watch-outs

What we like

Brand and compounded medication offered through one clinician
The behavior-change program is included in every medication plan
A low-dose tier exists for buyers starting cautiously
The compounding disclosure is printed rather than buried

Watch-outs

The rate is billed against a twelve-week subscription, not a month
Two Noom pages quote different ongoing rates for the same program
No price appears outside the footnotes
Brand pricing is a clinician fee plus an unstated drug cost

Best for

Buyers who want habit coaching bundled with the prescription.

Who should look elsewhere

Anyone costing a year from a single published monthly rate.

How Noom compares

A few alternatives worth a look, depending on what you’re optimizing for.

SkinnyRx
A tirzepatide price you can check
See SkinnyRx →
Bodybuilding Health+
A headline that is the monthly rate
See Bodybuilding Health+ →
Synergy Rx
Compounded and branded together
See Synergy Rx →

Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Nex Gen Health RxNexLifeNextMedsNirwana HealthNoBsRxNolu

Hana Brennan

Pricing & provider data · Reviewed and last verified September 2026

How we assessed this. This review reflects GLP Loss’s own read of Noom’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What does the microdose program cost each month?: The program page states $79 for an initial three-week subscription that includes four weeks of medication, then $179 per month plus tax against a twelve-week subscription. Because twelve weeks is 84 days rather than three calendar months, three of those payments cover 2.76 months. The effective monthly cost is therefore higher than $179.
Why do two Noom pages give different prices?: The homepage footnote carries pricing dated March 31, 2026 and quotes $199 a month after the intro. The dedicated microdose page carries pricing dated July 27, 2026 and quotes $179. Both describe the same program with the same $79 opening, so the older footnote has simply not been updated.
Does Noom prescribe Wegovy and Zepbound?: Yes. Noom Med lists brand Wegovy, Ozempic, Zepbound, Mounjaro and the Wegovy pill alongside its own compounded programs. Brand access is described as starting at $39 plus the out-of-pocket cost of the medication, which depends on a buyer's insurance. That second component is never quantified on the site.
Is the compounded medication FDA-approved?: No. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. Noom states its compounded semaglutide is produced in an FDA-registered facility, which describes where it is made rather than any review of the product. Noom also states it has no affiliation with Novo Nordisk or Eli Lilly.
Is Noom expensive compared with other GLP-1 telehealth sellers providers?: Noom publishes a starting figure of $195/mo. Across the 226 GLP-1 telehealth sellers providers we review that publish a single monthly figure, those run $76 to $449 with a median of $179, which puts Noom above the median. The other 14 GLP-1 telehealth sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every seller we cover.